CH Biotech R&D Co., Ltd. (TPE:6534)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
113.00
+1.00 (0.89%)
Sep 30, 2025, 1:30 PM CST
0.89%
Market Cap11.51B
Revenue (ttm)1.68B
Net Income (ttm)364.31M
Shares Out102.80M
EPS (ttm)3.53
PE Ratio31.75
Forward PEn/a
Dividend4.10 (3.66%)
Ex-Dividend DateAug 21, 2025
Volume40,484
Average Volume101,879
Open112.00
Previous Close112.00
Day's Range111.00 - 113.50
52-Week Range71.10 - 123.50
Beta0.17
RSI55.17
Earnings DateNov 5, 2025

About CH Biotech R&D

CH Biotech R&D Co., Ltd., a biotech company, engages in the research and development of biotech drugs for agrochemical products in Taiwan, the United States, and internationally. The company offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd. was incorporated in 2013 and is based in Nantou City, Taiwan. [Read more]

Sector Materials
Founded 2013
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6534
Full Company Profile

Financial Performance

In 2024, CH Biotech R&D's revenue was 1.64 billion, an increase of 7.98% compared to the previous year's 1.51 billion. Earnings were 476.39 million, an increase of 2.83%.

Financial Statements

News

There is no news available yet.